Abbott Laboratories Statistics

Total Valuation

BVMF:ABTT34 has a market cap or net worth of BRL 817.72 billion. The enterprise value is 846.92 billion.

Market Cap	817.72B
Enterprise Value	846.92B

Important Dates

The last earnings date was Thursday, April 16, 2026.

Earnings Date	Apr 16, 2026
Ex-Dividend Date	Apr 14, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	81.10%
Float	1.73B

Valuation Ratios

The trailing PE ratio is 25.07 and the forward PE ratio is 16.66.

PE Ratio	25.07
Forward PE	16.66
PS Ratio	3.47
PB Ratio	2.97
P/TBV Ratio	6.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	25.97
EV / Sales	3.75
EV / EBITDA	13.50
EV / EBIT	18.79
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.27
Debt / EBITDA	1.13
Debt / FCF	n/a
Interest Coverage	17.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.99%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	8.07%
Revenue Per Employee	2.05M
Profits Per Employee	283,608
Employee Count	122,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BVMF:ABTT34 has paid 9.71 billion in taxes.

Income Tax	9.71B
Effective Tax Rate	22.87%

Stock Price Statistics

The stock price has decreased by -36.37% in the last 52 weeks. The beta is 0.78, so BVMF:ABTT34's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-36.37%
50-Day Moving Average	45.74
200-Day Moving Average	55.00
Relative Strength Index (RSI)	24.99
Average Volume (20 Days)	1,520

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.85

Income Statement

In the last 12 months, BVMF:ABTT34 had revenue of BRL 235.45 billion and earned 32.61 billion in profits. Earnings per share was 18.62.

Revenue	235.45B
Gross Profit	132.95B
Operating Income	47.02B
Pretax Income	42.45B
Net Income	32.61B
EBITDA	63.39B
EBIT	47.02B
Earnings Per Share (EPS)	18.62

Balance Sheet

The company has 46.63 billion in cash and 73.74 billion in debt, giving a net cash position of -27.11 billion.

Cash & Cash Equivalents	46.63B
Total Debt	73.74B
Net Cash	-27.11B
Net Cash Per Share	n/a
Equity (Book Value)	275.29B
Book Value Per Share	156.60
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	15.68B
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 56.47%, with operating and profit margins of 19.97% and 13.91%.

Gross Margin	56.47%
Operating Margin	19.97%
Pretax Margin	18.03%
Profit Margin	13.91%
EBITDA Margin	26.92%
EBIT Margin	19.97%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.73, which amounts to a dividend yield of 1.89%.

Dividend Per Share	0.73
Dividend Yield	1.89%
Dividend Growth (YoY)	0.18%
Years of Dividend Growth	6
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	1.85%
Earnings Yield	3.99%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 3.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	3

Scores

Altman Z-Score	n/a
Piotroski F-Score	2